Drug Profile
Estradiol/dydrogesterone
Alternative Names: Femoston; Femoston Conti; Femoston Conti Low-dose; Femoston ContinousLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Solvay Pharmaceuticals
- Developer Abbott Laboratories
- Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnadienes
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis